Multisensory Approaches for Managing Pediatric Dental Anxiety
Evaluation of the Effects of Virtual Reality and Weighted Blanket Use on Dental Anxiety Among School-Aged Children With High Dental Anxiety
The purpose of this prospective, randomized, single-blind clinical study is to evaluate and compare the effectiveness of distraction using virtual reality (VR) glasses and deep-pressure stimulation using weighted blankets on dental anxiety, cooperation, and pain perception in school-aged children. The study focuses on children aged 5-9 years with high dental anxiety (CFSS-DS score ≥39) who require dental procedures involving local anesthesia, such as Class II restorations, pulpotomy, or extractions. Participants will be randomly assigned to four groups: a control group receiving standard behavior guidance, a VR group, a weighted blanket group, and a combined group using both VR and weighted blankets. The study aims to determine the effects of these non-pharmacological, non-invasive, sensory-based interventions on children's clinical experience and physiological parameters.
調査の概要
状態
詳細な説明
This clinical trial is designed as a four-arm, randomized controlled study to compare sensory-based behavior guidance techniques in pediatric dentistry.
Study Arms:
Group 1 (Control): Treatment with basic behavior guidance techniques.
Group 2 (VR): Treatment using virtual reality (VR) glasses as a distraction tool.
Group 3 (WB): Treatment using a 3-kg weighted blanket for deep-pressure stimulation.
Group 4 (Combined): Simultaneous use of VR glasses and a weighted blanket.
Methodology:
Children aged 5-9 years who meet the inclusion criteria will be evaluated at multiple time points: pre-treatment, during local anesthesia, and post-treatment.
Outcome Measures:
Dental Anxiety: Assessed using the Facial Image Scale (FIS) and the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS).
Cooperation: Evaluated using the Frankl Behavior Rating Scale and the FLACC (Face, Legs, Activity, Cry, Consolability) scale.
Pain Perception: Measured using the Wong-Baker FACES Pain Rating Scale.
Physiological Parameters: Heart rate and oxygen saturation will be monitored throughout the procedure.
Acceptability: Subjective feedback from children and parents will be collected via post-treatment surveys to assess the feasibility of and satisfaction with the interventions.
Inclusion is restricted to systemically healthy children (ASA I-II) whose body weight (15-30 kg) is compatible with the 3-kg weighted blanket to ensure safety and appropriate therapeutic pressure.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：Ayşe Evirken, DDS
- 電話番号：+90 543 927 76 86
- メール：ayse.evirken@bezmialem.edu.tr
研究連絡先のバックアップ
- 名前：Mustafa Sarp Kaya, Associate Professor
- 電話番号：+90 532 230 68 01
- メール：mskaya@bezmialem.edu.tr
研究場所
-
-
Fatih
-
Istanbul、Fatih、トルコ（Türkiye）、34093
- 募集
- Bezm-i Alem Vakif University, Faculty of Dentistry, Department of Pediatric Dentistry
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Children aged between 5 and 9 years.
- Children with a total score of 39 or higher on the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS).
- Requirement for dental treatment necessitating local anesthesia, such as Class II restorations, pulpotomy, pulpectomy, or extractions.
- Systemically healthy children classified as ASA I or ASA II.
- Voluntary participation of both the child and the parent, with written informed consent obtained from the parent.
- Body weight between 15 and 30 kg, ensuring that the 3-kg weighted blanket corresponds to 10-20% of the child's body weight.
Exclusion Criteria:
- Children with a CFSS-DS score of 38 or lower.
- Presence of intellectual or developmental disabilities.
- Presence of visual or hearing impairments.
- Presence of neurodevelopmental or neurological disorders, such as epilepsy.
- Acute or chronic respiratory diseases.
- Neuromuscular or orthopedic conditions that may pose a risk during the use of the weighted blanket.
- History of dizziness, nausea, or vertigo associated with virtual reality use.
- Refusal of the specific interventions, namely VR glasses or the weighted blanket, by the child or the parent.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ：Control Group
Participants in this group will receive dental treatment using only basic behavior guidance techniques, such as tell-show-do and positive reinforcement, without any additional sensory interventions. |
Traditional non-pharmacological behavior management techniques, including the "Tell-Show-Do" method, positive reinforcement, and distraction through verbal communication, will be used as a standard protocol. |
|
実験的：Virtual Reality Group
Participants will wear virtual reality (VR) glasses during the dental procedure. The VR system will be used as a visual and auditory distraction tool to reduce dental anxiety and pain perception. |
The participant will wear a Virtual Reality headset during the dental procedure. Audio-visual content specifically selected for pediatric distraction will be played to divert the child's attention away from dental stimuli and reduce anxiety. |
|
実験的：Weighted Blanket Group
Participants will be covered with a 3-kg weighted blanket during the dental procedure to provide deep-pressure stimulation. This non-pharmacological intervention aims to promote relaxation and reduce physiological stress responses. |
A 3 kg weighted blanket will be placed over the participant's body during the dental treatment. This intervention aims to provide deep pressure stimulation to promote relaxation and decrease behavioral stress responses. |
|
実験的：Combined Intervention Group
Participants in this group will receive a combination of the two interventions during the entire dental procedure: virtual reality (VR) glasses for distraction and a weighted blanket for deep-pressure stimulation. |
The participant will wear a Virtual Reality headset during the dental procedure. Audio-visual content specifically selected for pediatric distraction will be played to divert the child's attention away from dental stimuli and reduce anxiety. A 3 kg weighted blanket will be placed over the participant's body during the dental treatment. This intervention aims to provide deep pressure stimulation to promote relaxation and decrease behavioral stress responses. |
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Children's Fear Survey Schedule-Dental Subscale (CFSS-DS) Score
時間枠：During the dental examination session, before dental treatment.
|
Dental fear and anxiety will be assessed using the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS). The total score ranges from 15 to 75, with higher scores indicating greater dental fear and anxiety. |
During the dental examination session, before dental treatment.
|
|
Facial Image Scale (FIS) Score
時間枠：Immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment.
|
Dental anxiety will be assessed using the Facial Image Scale (FIS), a 5-point facial image scale ranging from 1 to 5, with higher scores indicating greater dental anxiety. FIS scores will be recorded at three time points: immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment. |
Immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment.
|
|
Frankl Behavior Rating Scale Score
時間枠：Immediately before dental treatment ande immediately after dental treatment.
|
Child behavior and cooperation during dental treatment will be assessed using the Frankl Behavior Rating Scale, which categorizes behavior into four levels ranging from definitely negative to definitely positive. |
Immediately before dental treatment ande immediately after dental treatment.
|
|
FLACC Behavioral Pain Assessment Score
時間枠：Immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment.
|
Pain-related behavioral responses will be assessed using the FLACC (Face, Legs, Activity, Cry, Consolability) scale. The total score ranges from 0 to 10, with higher scores indicating greater pain-related behavioral response. Assessment will be performed by an independent evaluator blinded to group allocation using standardized video recordings. |
Immediately before dental treatment, immediately after local anesthetic injection, and immediately after completion of dental treatment.
|
|
Wong-Baker FACES Pain Rating Scale Score
時間枠：Immediately before and immediately after local anesthetic injection.
|
Self-reported pain intensity will be assessed using the Wong-Baker FACES Pain Rating Scale, ranging from 0 to 10, with higher scores indicating greater pain intensity. |
Immediately before and immediately after local anesthetic injection.
|
|
Heart Rate
時間枠：Immediately before dental treatment, immediately before and immediately after local anesthetic injection and immediately after completion of dental treatment.
|
Heart rate will be measured in beats per minute (bpm) using a pulse oximeter. |
Immediately before dental treatment, immediately before and immediately after local anesthetic injection and immediately after completion of dental treatment.
|
|
Peripheral Oxygen Saturation (SpO₂)
時間枠：Immediately before dental treatment, immediately before and immediately after local anesthetic injection and immediately after completion of dental treatment.
|
Peripheral oxygen saturation (SpO₂) will be measured using a pulse oximeter and recorded as percentage (%). |
Immediately before dental treatment, immediately before and immediately after local anesthetic injection and immediately after completion of dental treatment.
|
協力者と研究者
捜査官
- 主任研究者：Mustafa Sarp Kaya, Associate Professor、Bezm-i Alem Vakif University, Faculty of Dentistry, Department of Pediatric Dentistry
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 2026/915
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Individual participant data will not be shared to protect participant confidentiality and privacy in accordance with the ethical committee approval and local data protection regulations.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。